IP
InterWest Partners
Venture CapitalActiveInterWest invests an average of about $7 - 15 million over the span of their involvement with each company in their portfolio.
405
Investments
7
Exits
null
AUM
1.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for InterWest Partners.
Investment Thesis & Strategy
InterWest Partners invests in biotech, fintech, and venture capital companies, typically committing $7-15 million across various stages of investment.
Investment Activity
Deals per year over the last 14 years
1
20010
20021
20031
20041
20051
20061
20072
20080
20090
20100
20110
20120
20131
2014Portfolio Companies
Selected investments from their portfolio of 405 companies
O
Onyx Pharmaceuticals
Biotech · Series A, 0
N
Neurocrine Biosciences
Biotech · Series A, 0
T
Threshold Pharmaceuticals
Biotech · Series A, 0
C
Corvus Pharmaceuticals
Biotech · Series A, 2014
A
Agios Pharmaceuticals
Biotech · Series A, 2008
N
Natera
Healthcare · Series B, 2008
G
GI Dynamics
Healthcare · Series A, 2007
C
Calithera Biosciences
Biotech · Series A, 2006
P
Portola Pharmaceuticals
Biotech · Series A, 2005
P
Proteolix
Biotech · Series A, 2004
A
Achaogen
Biotech · Series A, 2003
M
Medivation
Biotech · Series A, 2001
Notable Exits
CompanyTypeYearValue / Acquirer
Phone.comIPO2024—
AlteryxIPO2017—
MarketoAcquisition2016—
TIBCO SoftwareAcquisition2014—
SourcefireAcquisition2013—
Cornerstone OnDemandIPO2011—
VertaforeAcquisition2010—
Frequently Asked Questions
InterWest Partners focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Threshold
Menlo Park, United States · 841 deals
Lightspeed Venture Partners
Menlo Park, United States · 839 deals
Andreessen Horowitz
Menlo Park, United States · 826 deals
Khosla Ventures
Menlo Park, United States · 769 deals
Greylock
Menlo Park, United States · 720 deals
GGV Capital
Menlo Park, United States · 625 deals